Tissue-engineered hearts using multimodal printing in newborns (thumpin)
Active Other Transaction Agreement Awarded Last action
- Contract number
- 140D042690026
- Awardee
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $11,227,969
Award facts
- Contract value 38% obligated
-
- $11,227,969.02 Current, with exercised options
- $29,311,060.04 Potential, with all options
- Completion date 3% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institutes of Health Department of Health and Human Services
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health awarded an Other Transaction Agreement to The Children's Hospital Corporation (doing business as Boston Children's Hospital) on September 1, 2026, for Tissue-Engineered Hearts Using Multimodal Printing in Newborns (THUMPIN), with a ceiling value of $29,311,060.04.
This OTA sits outside the FAR and funds a research and development effort in regenerative medicine and bioprinting technology for pediatric cardiac applications. Performance runs through August 31, 2031, at Boston Children's Hospital in Boston, Massachusetts. The Children's Hospital Corporation is a nonprofit pediatric teaching hospital and Harvard Medical School affiliate operating as a federal research institution, conducting translational science and biomedical research for the federal government. The OTA represents a departure from the institution's primary portfolio of NIH research grants and cooperative agreements, extending into the transaction-based mechanism. As a leading pediatric research center with substantial prior NIH funding across cardiovascular disease, developmental biology, and regenerative medicine, Boston Children's Hospital brings relevant capability in multi-site translational research and clinical trial execution. Subcontractors or academic partners, if named in the award documentation, are not identified in the available source material.
Quick answers
Who was awarded contract 140D042690026?
140D042690026 was awarded to The Children's Hospital Corporation by Interior Business Center (Office of Policy Management and Budget) on September 1, 2026.
How much is contract 140D042690026 worth?
The government has obligated $11,227,969 on 140D042690026. Its potential value, with all options, is $29,311,060.
Which agency awarded contract 140D042690026?
Interior Business Center (Office of Policy Management and Budget) awarded 140D042690026, with funding from National Institutes of Health (Department of Health and Human Services).
Was contract 140D042690026 competed?
The extent of competition for 140D042690026 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award